Title:
抗-CD100抗体の使用
Document Type and Number:
Japanese Patent JP4768597
Kind Code:
B2
Abstract:
The invention relates to the use a BD16 and/or BB18 anti-CD100 antibody or of a chimeric or humanized form thereof, or a fragment thereof, for the therapy or diagnosis of a central nervous system disorder, more particularly a myelin disorder or a disease that affects oligodendrocytes, such as multiple sclerosis or HTLV-1 associated myelopathy.
Inventors:
Berry, Marie-Francoise
Girodon, Pascal
Bumsur, Lawrence
Ben Susan, Armand
Girodon, Pascal
Bumsur, Lawrence
Ben Susan, Armand
Application Number:
JP2006501920A
Publication Date:
September 07, 2011
Filing Date:
February 02, 2004
Export Citation:
Assignee:
Institute National de la Santé de la Cherche Medical (JNSW A/M)
International Classes:
A61K39/395; A61P25/00; A61P25/02; A61P25/28; A61P29/00; A61P31/14; A61P35/02; A61P37/06; A61P43/00; C07K16/28; G01N33/53; G01N33/577
Foreign References:
| WO1993014125A1 | 1993-07-22 |
Attorney, Agent or Firm:
Atsushi Aoki
Takashi Ishida
Fukumoto product
Tetsuji Koga
Kazumi Nakamura
Masaya Nishiyama
Takashi Ishida
Fukumoto product
Tetsuji Koga
Kazumi Nakamura
Masaya Nishiyama